Cargando…

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

Capicua-double homeobox 4 (CIC-DUX4)–rearranged sarcomas (CDS) are extremely rare, highly aggressive primary sarcomas that represent a major therapeutic challenge. Patients are treated according to Ewing sarcoma protocols, but CDS-specific therapies are strongly needed. In this study, RNA sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrabotta, Marianna, Laginestra, Maria Antonella, Durante, Giorgio, Mancarella, Caterina, Landuzzi, Lorena, Parra, Alessandro, Ruzzi, Francesca, Toracchio, Lisa, De Feo, Alessandra, Giusti, Veronica, Pasello, Michela, Righi, Alberto, Lollini, Pier-Luigi, Palmerini, Emanuela, Donati, Davide Maria, Manara, Maria Cristina, Scotlandi, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Translational Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359717/ https://www.ncbi.nlm.nih.gov/pubmed/34903601 http://dx.doi.org/10.1158/0008-5472.CAN-21-1222

Ejemplares similares

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers
por: Mancarella, Caterina, et al.
Publicado: (2022)

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Nanni, Patrizia, et al.
Publicado: (2019)

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
por: Zucchini, Cinzia, et al.
Publicado: (2019)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
por: Mancarella, Caterina, et al.
Publicado: (2018)

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021)

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
por: Mancarella, Caterina, et al.
Publicado: (2023)

Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
por: Garofalo, Cecilia, et al.
Publicado: (2013)

Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma
por: Bosnakovski, Darko, et al.
Publicado: (2021)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

CD99 at the crossroads of physiology and pathology
por: Pasello, Michela, et al.
Publicado: (2018)

CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
por: Manara, Maria Cristina, et al.
Publicado: (2018)

Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models
por: Hendrickson, Peter G., et al.
Publicado: (2023)

Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models
por: Hendrickson, Peter G., et al.
Publicado: (2023)

Cardiac Tamponade as an Unusual Initial Clinical Manifestation of CIC-DUX4 Sarcoma
por: Maekawa, Akira, et al.
Publicado: (2021)

Generation of novel patient-derived CIC-DUX4 sarcoma xenografts and cell lines
por: Oyama, Rieko, et al.
Publicado: (2017)

The CAM Model for CIC-DUX4 Sarcoma and Its Potential Use for Precision Medicine
por: Komatsu, Aoi, et al.
Publicado: (2021)

WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma
por: Ponce, Rovingaile Kriska M., et al.
Publicado: (2022)

CIC-DUX4 Sarcoma Involving the Skull Base: A Rare Presentation and Review of the Literature
por: Hobday, Sara B., et al.
Publicado: (2023)

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
por: Chiarini, Francesca, et al.
Publicado: (2022)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
por: Mancarella, Caterina, et al.
Publicado: (2020)

A Rare Case of Round Cell Sarcoma with CIC-DUX4 Mutation Mimicking a Phlegmon: Review of Literature
por: Donthi, Deepak, et al.
Publicado: (2020)

CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling
por: Manara, Maria Cristina, et al.
Publicado: (2016)

A case report of CIC–DUX4 fusion-positive sarcoma in the pelvic cavity with targeted next-generation sequencing results
por: Wu, Qian, et al.
Publicado: (2022)

CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma
por: Odintsov, Igor, et al.
Publicado: (2022)

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1
por: Palmerini, Emanuela, et al.
Publicado: (2017)

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
por: Guerzoni, Clara, et al.
Publicado: (2014)

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
por: Setola, Elisabetta, et al.
Publicado: (2023)

A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response
por: Pellegrini, Evelin, et al.
Publicado: (2022)

IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
por: Mancarella, Caterina, et al.
Publicado: (2020)

Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the BCOR-CCNB3- & CIC-DUX4-positive sarcomas
por: Rekhi, Bharat, et al.
Publicado: (2019)

Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs
por: Nakai, Sho, et al.
Publicado: (2019)

Erratum: Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the BCOR-CCNB3- & CIC-DUX4-positive sarcomas
Publicado: (2020)

IFN-γ and CD38 in Hyperprogressive Cancer Development
por: Angelicola, Stefania, et al.
Publicado: (2021)

Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma
por: Martinelli, Marcella, et al.
Publicado: (2022)

CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report
por: Vieira, Aline Cristini, et al.
Publicado: (2021)

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
por: Palmerini, Emanuela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n7jd4qvutd8ctphj93dpnb6ik9